Back to results
Recruiting

A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

NCT06322667

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Eisai trial site 2

Hiroshima, Japan

+2 additional locations

Contact

Eisai Inquiry Service.

eisai-chiken_hotline@hhc.eisai.co.jp
View on ClinicalTrials.gov
A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab — TrialFind